Medical Device Coating Market Analysis | 2022-2028

Market Dynamics

Introduction

Medical device coatings (MDCs) are materials that improve a medical gadget's function and mobility. MDCs are used to protect the surfaces of many medical equipment, including those used in dentistry, neurology, and other fields. By using them, one can achieve optimal hygienic conditions, corrosion resistance, and biocompatibility. Their use lessens blood vessel injuries, allergic responses, and thrombogenicity.

Additionally, the coatings on medical devices have a variety of various characteristics, such as the ability to be either hydrophilic or hydrophobic. Additionally, these coatings are employed on a wide range of medical devices, including those used in gynaecological, cardiothoracic, orthopaedic, and dental implants, as well as general surgery.

Market Dynamics

An increase in the frequency of hospital-acquired infections is what is fueling the growth of the medical device coating industry (HAI). For instance, the usage of contaminated devices might spread hospital-acquired infections, necessitating medical device coating to stop HAIs. As a result, the antimicrobial qualities of medical device coatings can aid in the prevention of HAIs, increasing demand for them and, in turn, the market's expansion.

Additionally, factors including the increase in disorders like orthopaedic and cardiovascular diseases, which call for the use of medical coating devices, are fueling the market's expansion. The care of heart failure using medical device coatings (VADs) as DT and bridges. Furthermore, a rise in interest in minimally invasive medical technologies has spurred their use in a variety of surgical specialties.        

Other factors that contribute to the market's expansion include the development and introduction of novel medical devices, strict regulatory guidelines regarding MDC, rising implanted device demand, and an increase in the world's population's disposable income. The market expansion of MDCs could be constrained by the severe government constraints in this area. Additionally, it is anticipated that the market expansion will be constrained by the frequent changes in raw material prices and the lengthy regulatory approval processes.

On the other hand, untapped potential in developing nations like China and India as well as the advancement of multifunctional coatings are predicted to offer market participants profitable prospects. Additionally, the market for medical device coating is anticipated to see lucrative chances soon due to increasing demand for nanocoating.

Recent Developments

Medical device coating is a highly competitive market. To remain competitive in this market, market participants are placing a lot of emphasis on mergers, expansions, and product approvals. Here are a few significant developments:

• In April 2022, Biocoat, Inc., a provider of hydrophilic biomaterial coatings and coating tools for medical devices, declared that it will be expanding into the design, development, and supply of hydrophilic dip coating tools. The EMERSE equipment line from Biocoat is available to businesses that need an in-house dip coating system to finish the production of their medical devices.
• In September 2021, Hydromer, a global provider of coatings for industrial and medical applications, announced the opening of its brand-new plant, which has a wide range of new capabilities. The new facility was built following the most recent standards and is fully FDA certified, ISO9001:2015, and ISO13485:2016 authorized. It was created to accommodate all of the company's functions and provide notable services, namely the production of coatings that can be heat or UV-cured, in solvent and water base versions to fit any sort of coating requirements, a wide variety of surface modification procedures, contract development and supply of custom coatings according to customers' specifications, among other services
• In August 2020, as an exclusive coatings provider and manufacturing partner for N8 Medical's CeraShield-coated endotracheal tubes, Hydromer revealed that the CeraShield coating has recently undergone tests that showed it can block and minimize the growth of COVID-19 virus on tube surfaces. A statistically significant decline in COVID-19 viral proliferation on the tube surface was observed after 60 minutes of testing
• In February 2020, Biocoat, Inc., a developer of hydrophilic biomaterial coatings for medical devices, announced the availability of HYDAK UV. The updated HYDAK coating was created to be cured by ultraviolet (UV) radiation, enabling flexible integration with UV coating equipment that is industry standard. The cutting-edge coating is based on the tried-and-true bi-laminar architecture that is the foundation of Biocoat's current thermal heat cure coating technology
• In January 2016, a partnership between DSM Biomedical and Vention Medical was established to give customers who develop and produce coated medical devices a single-source solution. DSM Biomedical is a world leader in biomedical materials research and regenerative medicine. Customers are now offered the opportunity to incorporate the development, testing, and application of DSM's ComfortCoat coating into the catheter production process, removing the need to send finished goods to a different supplier for services related to coating application and development.

Segments Analysis

By Material Type

The market is segmented into metals, ceramics, and polymers. The metals segment is further segmented into silver, titanium, and others, whereas the polymers segment is divided into silicone, perylene, fluoropolymers, PTFE, PVDF, and others.

By Coating Type

The market is segmented into hydrophilic, and hydrophobic. Abrasion resistance, lubricity, biocompatibility, and non-thrombogenic are all characteristics of hydrophilic coatings. Because of these qualities, these coatings can be used to cover guide wires, vascular catheters, and other medical devices that are utilized to treat some very prevalent disorders, including orthopaedic and cardiovascular conditions.

By Application Type

“The growth of the general surgery market is fueled by a rise in general procedures and the use of related devices”.

The market is segmented into general surgery, cardiovascular, orthopedics, dental, neurology, gynecology, and others. The expansion of this dominant market category of general surgery is driven by an increase in the number of general procedures including the use of such devices. As medical device coatings work to prevent hospital-acquired infections from spreading through medical devices, strict rules prohibiting their use are also crucial drivers in growth.

Due to the rise in the frequency of orthopaedic illnesses, which necessitate a significant use of medical devices that require medical device coatings, the orthopaedics segment is also anticipated to develop at the quickest rate over the projection year.

Regional Analysis

“North America is expected to be the leading region in the medical device coating market in 2021”.

The medical device coating market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2021, North America is anticipated to be the medical device coating market's largest region owing to the increased product launches, approvals, and initiatives by firms.

Key Players

The following are the key players in the Medical Device Coating Market (arranged alphabetically)

• AST Products, Inc.
• Bayer AG
• Biocoat Incorporated
• Covalon Technologies Ltd
• DSM
• Harland Medical Systems
• Hydromer, Inc.
• KISCO Ltd
• Precision Coating Co., Ltd.
• Surmodics, Inc. 

The overall competitive landscape has been affected due to these mergers and acquisitions. 

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research:

Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.